Inteligex
Biotechnology Research
Toronto, Inteligex Inc. 781 followers
Inteligex is working to develop novel stem cell and drug-based therapies for the treatment of Spinal Cord Injury.
About us
Inteligex is a cell therapy company focused on solving currently incurable conditions of the central nervous system.
- Website
-
https://inteligex.ca/
External link for Inteligex
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Toronto, Inteligex Inc.
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Stem Cells, Spinal Cord Injury, Neural Stem Cells, and Central Nervous System
Locations
-
Primary
Get directions
100 College Street,
Suite 79
Toronto, Inteligex Inc. M5G 1L5, CA
Employees at Inteligex
-
Jose L. Rodriguez
-
Christopher Ahuja
Neurosurgeon at Northwestern Medicine Scientist at Simpson-Querrey Research Institute, Northwestern University Chief Medical Officer, Inteligex Inc
-
Tim Worden
Equestrian Sports Performance Consultant
-
Paul Bradshaw
Chief Executive Officer and Chief Operating Officer at Inteligex Inc.
Updates
-
Inteligex reposted this
𝐒𝐩𝐢𝐧𝐚𝐥 𝐂𝐨𝐫𝐝 𝐈𝐧𝐣𝐮𝐫𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦: Inteligex CEO Paul Bradshaw on stem cells that are designed to account for regional identity differences within the spinal cord, and also engineering in a proliferation factor. He explains how Inteligex's "ReStaRT Cells" are designed with a regional identity, and the rationale for engineering them to express the ChABC and GDNF genes to boost the odds of survival and proliferation. Full video: https://lnkd.in/gvuKf98G BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent